back to top
HomeTagsMyeloma

Myeloma

CARVYKTI ® is the First and Solely Cell Remedy to Considerably Lengthen Total Survival In comparison with Normal of Care in Sufferers with A...

Landmark CARTITUDE-4 research outcomes present CARVYKTI ® lowered the danger of dying by 45 % after three-year follow-upLate-breaking information featured in an oral presentation...

Most Popular

spot_img